Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in COGT — Cogent Biosciences, Inc.

CIK 1423053 MIAMI, FL
Back to COGT Full portfolio

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$32,883,157
-$33,124,383 QoQ
Shares Held
849,694
-50.5% QoQ
Ownership
0.490%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#50
of 321 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COGT Over Time

Shares Held

Position Value (USD)

Derivatives in COGT

reported options exposure · as of Jun 30, 2026
CallValue
$5,719,860
CallShares
147,800
PutValue
$2,910,240
PutShares
75,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. COGT ranks #38 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in COGT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,883,157 849,694
2026-06-30 $2,910,240 75,200
2026-06-30 $5,719,860 147,800
2026-03-31 $3,498,741 90,900
2026-03-31 $3,910,584 101,600
2026-03-31 $66,007,540 1,714,927
2025-12-31 $2,596,512 73,100
2025-12-31 $51,113,066 1,438,994
2025-12-31 $2,816,736 79,300
2025-09-30 $173,756 12,100
2025-09-30 $23,949,708 1,667,807
2025-09-30 $315,920 22,000
2025-06-30 $376,232 52,400
2025-06-30 $4,460,467 621,235
2025-06-30 $361,872 50,400
2025-03-31 $118,602 19,800
2025-03-31 $50,316 8,400
2025-03-31 $2,933,231 489,688
2024-12-31 $314,340 40,300
2024-12-31 $761,771 97,663
2024-12-31 $164,580 21,100
2024-09-30 $104,187 9,647
2024-09-30 $268,920 24,900
2024-09-30 $412,560 38,200
2024-06-30 $76,240 9,044
2024-06-30 $308,538 36,600
2024-06-30 $273,132 32,400
2024-03-31 $186,816 27,800
2024-03-31 $886,307 131,891
2024-03-31 $108,192 16,100
2023-12-31 $273,420 46,500
2023-12-31 $24,108 4,100
2023-12-31 $3,767,733 640,771
2023-09-30 $48,750 5,000
2023-09-30 $590,898 60,605
2023-09-30 $194,025 19,900
2023-06-30 $10,656 900
2023-06-30 $188,256 15,900
2023-06-30 $1,595,641 134,767
2023-03-31 $13,981,379 1,295,772
2023-03-31 $140,270 13,000
2023-03-31 $45,318 4,200
2022-12-31 $426,564 36,900
2022-12-31 $13,872 1,200
2022-12-31 $21,435,939 1,854,320
2022-09-30 $716,160 48,000
2022-09-30 $19,877,617 1,332,280
2022-09-30 $299,892 20,100
2022-06-30 $9,665,056 1,071,514
2022-06-30 $529,474 58,700

Report a Problem

Category
Description
Email (optional, for follow-up)